Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
54.56
-0.53 (-0.96%)
Mar 3, 2026, 4:00 PM EST - Market closed

Supernus Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
128.4569.3375.0593.12203.43
Short-Term Investments
180.22384.28179.82368.21136.25
Cash & Short-Term Investments
308.67453.61254.87461.33339.68
Cash Growth
-31.95%77.98%-44.75%35.81%-19.61%
Receivables
187.8142.08144.16165.5148.93
Inventory
82.3954.2977.4191.5485.96
Prepaid Expenses
65.3336.0916.6815.7827.02
Total Current Assets
644.18686.07493.11734.15601.59
Property, Plant & Equipment
10.5336.0242.5244.0852.32
Long-Term Investments
--16.6293.9119.17
Goodwill
124.88117.02117.02117.02117.52
Other Intangible Assets
569.46521.91599.89702.46784.69
Long-Term Deferred Tax Assets
38.35----
Other Long-Term Assets
65.257.058.5110.913.87
Total Assets
1,4531,3681,2781,7031,689
Accounts Payable
107.84.591.9610.549.33
Accrued Expenses
-180.21166.26185.67199.47
Current Portion of Long-Term Debt
---407.977.24
Current Portion of Leases
-6.898.336.796.48
Other Current Liabilities
230.37100.72113.6476.9992.86
Total Current Liabilities
338.17292.4290.2687.96315.38
Long-Term Debt
----385.23
Long-Term Leases
30.3727.3833.23641.3
Long-Term Deferred Tax Liabilities
-4.9624.9649.8185.36
Other Long-Term Liabilities
22.47.67.842.5446.04
Total Liabilities
390.93332.34356.16816.3873.3
Common Stock
0.060.060.060.050.05
Additional Paid-In Capital
543.83479.44439.49408.12434.34
Retained Earnings
517.88556.43482.56481.25379.92
Comprehensive Income & Other
-0.04-0.19-0.59-3.211.54
Shareholders' Equity
1,0621,036921.52886.2815.85
Total Liabilities & Equity
1,4531,3681,2781,7031,689
Total Debt
30.3734.2741.53450.76440.25
Net Cash (Debt)
278.31419.34229.96104.4718.6
Net Cash Growth
-33.63%82.35%120.12%461.74%-94.47%
Net Cash Per Share
4.937.494.141.690.34
Filing Date Shares Outstanding
57.4655.8154.7354.3853.39
Total Common Shares Outstanding
57.4655.7454.7254.2553.26
Working Capital
306.01393.67202.9246.19286.21
Book Value Per Share
18.4818.5816.8416.3315.32
Tangible Book Value
367.38396.8204.6166.72-86.36
Tangible Book Value Per Share
6.397.123.741.23-1.62
Machinery
-14.4814.0313.1114.23
Construction In Progress
---0.210.03
Leasehold Improvements
-14.0214.0214.0214.37
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q